BofA analyst Conor Fitzpatrick raised the firm’s price target on Calumet (CLMT) to $24 from $23 and keeps a Buy rating on the shares. The firm updates its price targets for Integrateds, Refining, and Midstream stocks under its coverage, the analyst tells investors. BofA notes the removal of Maduro in Venezuela and the unrest in Iran have lifted front month crude prices. The firm sees a blend of geopolitical and company specific catalysts ahead.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLMT:
- Elliott Backs Private Hypersonic Firm as U.S. Defense Spending Accelerates
- Calumet Specialty Products Completes Upsized Senior Notes Offering
- Calumet Specialty Products Prices New Senior Notes Offering
- Calumet Specialty Products Announces New Senior Notes Offering
- Calumet sees FY25 adjusted EBITDA $285M-$305M